Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$465K Buy
+3,615
New +$423K 0.16% 98
2024
Q4
Sell
-1,825
Closed -$207K 100
2024
Q3
$207K Sell
1,825
-3,970
-69% -$472K 0.11% 91
2024
Q2
$717K Sell
5,795
-68
-1% -$8.76K 0.44% 44
2024
Q1
$774K Sell
5,863
-1,589
-21% -$196K 0.48% 39
2023
Q4
$812K Sell
7,452
-8,332
-53% -$865K 0.77% 33
2023
Q3
$1.62M Sell
15,784
-15,891
-50% -$1.71M 1.79% 17
2023
Q2
$3.62M Sell
31,675
-356
-1% -$40.4K 3.81% 6
2023
Q1
$3.59M Hold
32,031
3.88% 5
2022
Q4
$3.59M Buy
+32,031
New +$3.27M 3.88% 5

Other funds holding MRK

Owen LaRue's MRK Position: Q2 2026 in Review

Owen LaRue opened a new position in Merck (MRK) in Q2 2026: 3,615 shares worth $465K. The stake represents 0.16% of the portfolio and ranks #98 among its holdings. This is a return to the name: Owen LaRue previously reported a position in MRK as recently as Q3 2024.

Owen LaRue first reported a position in MRK in Q4 2022 and has held it in 9 quarters since. The position peaked at $3.62M in Q2 2023. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Owen LaRue held 3,615 shares of Merck worth $465K as of Q2 2026.
  • Merck was a new Owen LaRue position in Q2 2026.
  • Merck made up 0.16% of Owen LaRue's portfolio in Q2 2026, its #98 holding.
  • Owen LaRue first reported a position in Merck in Q4 2022 and has held it in 9 quarters since.
  • Owen LaRue's Merck position peaked at $3.62M in Q2 2023.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Owen LaRue's 13F filing for Q2 2026, filed 22 Jul 2026.